In our study, we used peripheral blood samples from patients with NSCLC to demonstrate a negative prognostic value of PD-1 in this population, i.e. high expression of PD-1 associates with poor PFS and OS. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.